BioSpace News Archive

Enalare Therapeutics Inc., a clinical stage biopharmaceutical company dedicated to developing novel therapies for patients suffering from acute respiratory conditions, announced today that it has completed formation of its scientific advisory board.

Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2020 results on Thursday, February 4, 2021 , before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eas

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) (“Entheon” or the “Company”), a biotechnology company focused on developing psychedelic medicines to treat addiction, announces that it has entered into a consulting agreement (the “Agreement”) with Star Finance GmbH (“Star Finance”), a Swiss-based company, to provide European investor relations services. Star Finance has offices in Steinhausen, Switzerland, and Cologne, Germany.

As previously announced, Luminex Corporation (Nasdaq: LMNX) will present at the 39th Annual J.P. Morgan Healthcare Conference, to be held virtually today, January 13, 2021 at 3:30 p.m. Central Time

Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today the closing of its previously announced registered direct offering with a group of institutional investors of 1,810,000 shares of common stock at a price of $8.30 per share

Chengdu, China--(Newsfile Corp. - January 13, 2021) - Anticancer Bioscience (ACB), pioneers in synthetic lethal approaches to precision oncology, announced today announced that it is participating in Biotech Showcase Digital 2021, for the first time, providing an on-demand company presentation.

Blue Cross Blue Shield of Massachusetts (“Blue Cross”) has partnered with The Dimock Center to produce a new public health messaging video to support the COVID-19 vaccination effort.

Description: The latest report on ‘global platelet aggregation devices market’ encompasses an exhaustive analysis of this business sphere, inclusive of historical data, qualitative insights, and verifiable projections for 2020-2027.

Description: The business intelligence document on ‘Percutaneous Coronary Intervention (PCI) Devices Market’ provides thorough insights pertaining to this industry vertical, including revenue growth pattern and total valuation over 2020-2027.

A new Arthritis Research Canada study reveals rheumatoid arthritis patients have an increased risk of cardiovascular disease after diagnosis compared to the general population.